a total of 50 pediatric sepsis patients ages 14 years were selected from the patients hospitalized from november 2013 to october 2015. patients in the control group received basic treatment , and those in the baicalin group received basic treatment plus oral baicalin ( inner chengzi pharmaceutical , chifeng , china ) according to the manufacturer s instructions. thirty individuals were randomly divided into 3 groups : sham , clp , and clp + baicalin. 0191 and 0. since up regulated bax and down regulated bcl2. 2135 , figure 1a , 1b ) , while those of the baicalin group were significantly decreased after baicalin adjunctive therapy ( p=0. 0181 and 0.